Darunavir-cobicistat-emtricitabine-tenofovir alafenamide: safety and efficacy of a protease inhibitor in the modern era

Squillace, N; Bozzi, G; Colella, E; Gori, A; Bandera, A

Squillace, N (reprint author), Univ Milano Bicocca, Azienda Socio Sanit Terr Monza, San Gerardo Hosp, Infect Dis Unit, 33 Via Pergolesi, I-20900 Monza, Italy.

DRUG DESIGN DEVELOPMENT AND THERAPY, 2018; 12 (): 3635

Abstract

A fixed-dose combination consisting of darunavir (Drv), cobicistat (Cobi), emtricitabine (2',3'-dideoxy-5-fluoro-3'-thiacytidine [FTC]), and tenofovir......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索